Target intelligence / Profile preview

Measles virus internal proteins (MeV internal proteins)

Target
MeV internal proteins
Molecular classification
Viral protein, RNA-dependent RNA polymerase, Nucleocapsid protein, Phosphoprotein, Matrix protein
01

Overview

The internal proteins of the Measles virus (MeV) comprise the nucleoprotein (N), phosphoprotein (P), large protein (L), matrix protein (M), and the non-structural proteins V and C (UniProt: P03422, P03421, P08362, P06942). The N, P, and L proteins constitute the ribonucleoprotein (RNP) complex, which serves as the essential template for viral RNA transcription and replication, with the L protein acting as the catalytic RNA-dependent RNA polymerase (PubMed: 25344324). The M protein is a peripheral membrane protein that coordinates the assembly of these RNPs with the viral envelope at the host cell plasma membrane, a critical step for viral budding (PubMed: 21835787). Non-structural proteins V and C are primarily involved in antagonizing the host's innate immune response by inhibiting interferon signaling pathways (PubMed: 17110521). These proteins are key targets for antiviral development; for example, experimental inhibitors like ERDRP-0519 target the L protein to block RNA synthesis, while compounds like AS-136 aim to disrupt the N-P protein-protein interaction (PubMed: 22514371). Targeting these internal components is vital for treating severe measles cases and preventing fatal complications such as subacute sclerosing panencephalitis (SSPE).

Other names
Measles virus N, P, L, M, V, and C proteinsMeV ribonucleoprotein complexMeasles virus structural and non-structural internal proteins
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase activity, disruption of nucleocapsid assembly through N-P interaction inhibition, and interference with matrix protein-mediated viral budding.

03

Biological functions

Viral RNA replicationViral transcriptionViral assemblyImmune evasionGenome encapsidation
04

Disease associations

MeaslesSubacute sclerosing panencephalitisPneumoniaEncephalitis
05

Safety considerations

Development of antiviral resistance through viral mutationsPotential off-target effects on host RNA processingChallenges in crossing the blood-brain barrier for neurological complications
06

Interacting drugs

Ribavirin

3 more in the full profile.

07

Biomarkers

Measles virus RNAMeasles virus nucleoprotein antigenAnti-measles IgM antibodies

Beyond the preview

Go deeper on Measles virus internal proteins (MeV internal proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Measles virus internal proteins (MeV internal proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call